Publications

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

Title

Author

Year

A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.

Sirima, SB; Mordmüller, B; MILLIGAN, P; Ngoa, UA; Kironde, F; Atuguba, F; Tiono, AB; Issifou, S; Kaddumukasa, M; Bangre, O; Flach, C; Christiansen, M; Bang, P; Chilengi, R; Jepsen, S; Kremsner, PG; Theisen, M; GMZ2 Trial Study Group,;

2016

Vaccine, (2016).34 38 10.1016/j.vaccine.2016.07.041.

Countdown ODA+ Dataset.

Grollman, C; Arregoces, L; PITT, C; BORGHI, J; MARTINEZ-ALVAREZ, M; POWELL-JACKSON, T; Hsu, J; GRECO, G;

2016

, London School of Hygiene & Tropical Medicine (London, United Kingdom) (2016). 10.17037/DATA.107.

Composition and genetics of malaria vector populations in the Central African Republic.

NDIATH, MO; Eiglmeier, K; Olé Sangba, ML; Holm, I; Kazanji, M; Vernick, KD;

2016

Malaria journal, (2016).15 1 10.1186/s12936-016-1431-2.

Epidemiology and etiology of influenza-like-illness in households in Vietnam; it's not all about the kids!.

Nguyen, DN T; Mai, LQ; Bryant, JE; Hang, NL K; Hoa, LN M; NADJM, B; Thai, PQ; Duong, TN; Anh, DD; Horby, P; Van Doorn, HR; Wertheim, HF L; Fox, A;

2016

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, (2016).82, 10.1016/j.jcv.2016.07.014.

Clinical Presentation and Outcome of Ribavirin Treated RT-PCR Confirmed Lassa Fever Patients in ISTH Irrua: A Pilot Study.

Asogun, AD; Ochei, O; Moody, V; Abejegah, C; OKOH, E;

2016

Research in Health Science, (2016).1 2 10.22158/rhs.v1n2p68.

The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia.

Di Giorgio, L; Moses, MW; Fullman, N; Wollum, A; Conner, RO; ACHAN, J; Achoki, T; Bannon, KA; Burstein, R; Dansereau, E; DeCenso, B; Delwiche, K; Duber, HC; Gakidou, E; Gasasira, A; Haakenstad, A; Hanlon, M; Ikilezi, G; Kisia, C; Levine, AJ; Maboshe, M; Masiye, F; Masters, SH; Mphuka, C; Njuguna, P; ... Flaxman, AD.

2016

BMC medicine, (2016).14 1 10.1186/s12916-016-0653-z.

Sex-Differential Non-Vaccine-Specific Immunological Effects of Diphtheria-Tetanus-Pertussis and Measles Vaccination.

Noho-Konteh, F; Adetifa, JU; Cox, M; Hossin, S; Reynolds, J; Le, MT; Sanyang, LC; DRAMMEH, A; Plebanski, M; Forster, T; Dickinson, P; Ghazal, P; WHITTLE, H; Rowland-Jones, SL; SUTHERLAND, JS; Flanagan, KL;

2016

Clinical infectious diseases, (2016).63 9 10.1093/cid/ciw492.

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.

Lemoine, M; Shimakawa, Y; Njie, R; Taal, M; NDOW, G; Chemin, I; Ghosh, S; Njai, HF; Jeng, A; Sow, A; Toure-Kane, C; Mboup, S; Suso, P; Tamba, S; Jatta, A; Sarr, L; Kambi, A; Stanger, W; Nayagam, S; Howell, J; Mpabanzi, L; Nyan, O; Corrah, T; WHITTLE, H; Taylor-Robinson, SD; ... PROLIFICA investigators,

2016

The Lancet Global health, (2016).4 8 10.1016/S2214-109X(16)30130-9.

Unilateral breast dysfunction in lactating Gambian women.

Prentice, A; PRENTICE, AM;

2016

Annals of tropical paediatrics, (2016).4 1 10.1080/02724936.1984.11748300.

A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron.

BAH, A; Wegmuller, R; CERAMI, C; Kendall, L; Pasricha, S-R; MOORE, SE; PRENTICE, AM;

2016

BMC pregnancy and childbirth, (2016).16 1 10.1186/s12884-016-0934-8.